Hydatid Lung Disease

Tropical Lung Disease, Second Edition: Volume 211

Volumn 211, Issue , 2005, Pages 327-350

  Gottstein, Bruno ^a   Reichen, J Ü Rg ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247172011     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14118-18     Document Type: Chapter

References (104)

1. Thompson RCA, McManus DP. Towards a taxonomic revision of the genus Echinococcus. Trends Parasitol 2002; 18:452-457.
2. Eckert J, Gemmel MA, Meslin FX, Pawlowski ZS. WHO/OIE Manual on Echinococcosis in Humans and Animals: a Public Health Problem of Global Concern. Paris: OIE/WHO, 2001.
3. Deplazes P, Eckert J. Veterinary aspects of alveolar echinococcosis—a zoonosis of public health significance. Vet Parasitol 2001; 98:65-87.
4. Scott JC, Stefaniak J, Pawlowski ZS, McManus DP. Molecular genetic analysis of human cystic hydatid cases from Poland. Identification of a new genotypic group (G9) of Echinococcus granulosus. J Parasitol 1997; 114:37-43.
5. Haag KL, Zaha A, Araujo AM, Gottstein B. Reduced genetic variability within coding and non-coding regions of the Echinococcus multilocularis genome. Parasitology 1997; 115:521-529.
6. Gottstein B, Bettens F. Association between HLA-DR13 and susceptibility to alveolar echinococcosis. J Infect Dis 1994; 169:1416-1417.
7. Eiermann TH, Bettens F, Tiberghien P, Schmitz K, Beurton I, Bresson-Hadni S, Ammann RW, Goldmann SF, Vuitton DA, Gottstein B, Kern P. HLA and alveolar echinococcosis. Tissue Antigens 1998; 52:124-129.
8. Shcherbakov AM. Human echinococcosis: the role of histocompatibility antigens in realizing infestations and the characteristics of their course. Med Parazitol 1993; 5:13-18.
9. Ozhan MH. Pulmonary hydatidosis: state of the art. Int Arch Hydatidosis 2001; 34:11.
10. Salinas JC, Torcal J, Lozano R, et al. Intracystic infection of liver hydatidosis. Hepatogastroenterol 2000; 47:1052-1055.
11. Rebhandl W, Turnbull J, Felberbauer FX, et al. Pulmonary echinococcosis (hydatidosis) in children: results of surgical treatment. Pediatr Pulmonol 1999; 27:336-340.
12. Lamy AL, Cameron BH, Le Blanc JG, et al. Giant hydatid lung cysts in the Canadian northwest: outcome of conservative treatment in three children. J Pediatr Surg 1993; 28:1140-1143.
13. Kervancioglu R, Bayram M, Elbeyli L. CT findings in pulmonary hydatid disease. Acta Radiol 1999; 40:510-514.
14. Ramos G, Orduna A, Garcia-Yuste M. Hydatid cyst of the lung: diagnosis and treatment. World J Surg 2001; 25:46-57.
15. Rothlin MA. Fatal intraoperative pulmonary embolism from a hepatic hydatid cyst. Am J Gastroenterol 1998; 93:2606-2607.
16. Akinoglu A, Demiryurek H, Guzel C. Alveolar hydatid disease of the liver: a report on thirty-nine surgical cases in eastern Anatolia, Turkey. Am J Trop Med Hyg 1991; 45:182-189.
17. Ammann RW, Eckert J. Cestodes: Echinococcus. Gastroenterol Clin North Am 1996; 25:655-689.
18. Etievent JP, Vuitton D, Allemand H, et al. Pulmonary embolism from a parasitic cardiac clot secondary to hepatic alveolar echinococcosis. J Cardiovasc Surg 1986; 27:671-674.
19. Wilson JF, Rausch RL. Alveolar hydatid disease: a review of clinical features of 33 indigenous cases of E. multilocularis infection in Alaskan Eskimoes. Am J Trop Med Hyg 1980; 29:1340-1355.
20. Lampl L, Hamperl WD. Curative en-bloc resection (lung, diaphragm, liver, adrenal gland and thoracic wall) for Echinococcus multilocularis. Report of an unusual disease course. Langenbecks Arch Chir 1992; 377:68-70.
21. Bresson-Hadni S, Miguet JP, Lenys D, et al. Recurrence of alveolar echinococcosis in the liver graft after liver transplantation. Hepatology 1992; 16:279-280.
22. Gottstein B, Felleisen R. Protective immune mechanisms against the metaces-tode of Echinococcus multilocularis. Parasitol Today 1995; 11:320-326.
23. Dai WJ, Gottstein B. Nitric oxide-mediated immunosuppression following murine Echinococcus multilocularis infection. Immunology 1999; 97:107-116.
24. Ferreira AM, Irigoin F, Breijo M, et al. How Echinococcus granulosus deals with complement. Parasitol Today 2000; 16:168-172.
25. Dixon JB. Echinococcosis. Comp Immunol Microbiol Infect Dis 1997; 20:87-94.
26. Ellis ME, Sinner W, Asraf AM, et al. Echinococcal disease and mycobacterial infection. Ann Trop Med Parasitol 1991; 85:243-251.
27. Rigano R, ProfUmo E, Siracusano A. New perspectives in the immunology of Echinococcus granulosus infection. Parassitologia 1997; 39:275-277.
28. Ortona E, Rigano R, Buttari B, Delunardo F, loppolo S, Margutti P, ProfUmo E, Teggi A, Vaccari S, Siracusano A. An update on immunodiagnosis of cystic echinococcosis. Acta Trop 2003; 85:165-171.
29. Godot V, Harraga S, Podoprigora G, Liance M, Bardonnet K, Vuitton DA. IFN alpha-2a protects mice against a helminth infection of the liver and modulates immune responses. Gastroenterology 2003; 124(5):1441-1450.
30. Eger A, Kirch A, Manfras B, Kern P, Schulz-Key H, Soboslay PT. Pro-inflammatory (IL-1beta, IL-18) cytokines and IL-8 chemokine release by PBMC in response to Echinococcus multilocularis metacestode vesicles. Parasite Immunol 2003; 25(2):103-105.
31. Harraga S, Godot V, Bresson-Hadni S, Mantion G, Vuitton DA. Profile of cytokine production within the periparasitic granuloma in human alveolar echinococcosis. Acta Trop 2003; 85(2):231-236.
32. Emery I, Liance M, Deriaud E, Vuitton D, Houin R, Leclerc C. Characterization of T-cell immune responses of Echinococcus multilocularis infected C57BL/6 mice. Parasite Immunol 1996; 18:463-472.
33. Gottstein B, Hemphill A. Immunopathology of echinococcosis. Chem Immunol 1997; 66:177-208.
34. Bresson-Hadni S, Liance M, Meyer JP, Houin R, Bresson JL, Vuitton D. Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice. Clin Exp Immunol 1990; 82:378-383.
35. Sailer M, Soelder B, Allerberger F, Zaknun D, Feichtinger H, Gottstein B. Alveolar echinococcosis of the liver in a six-year-old girl with acquired immunodeficiency syndrome. J Pediatr 1997; 130:320-323.
36. Pawlowski ZS, Eckert J, Vuitton DA, et al. Echinococcosis in humans: clinical aspects, diagnosis and treatment. In: Eckert J, Gemell MA, Meslin FX, et al., eds. WHO/OIE Manual on Echinococcosis in Humans and Animals: a Public Health Problem of Global Concern. Paris: WHO and OIE, 2001:20-71.
37. Kilinc O, Sakar A, Yorgancioglu A, et al. Interesting pulmonary hydatid cyst cases mimicking other pulmonary diseases. Int Arch Hydatidosis 2001; 34:189.
38. Hira PR, Lindberg LG, Francis I, et al. Diagnosis of cystic hydatid disease: role of aspiration cytology. Lancet 1988; ii: 655-657.
39. Frydman CP, Raissi S, Watson CW. An unusual pulmonary and renal presentation of echinococcosis. Report of a case. Acta Cytol 1989; 33:655-658.
40. Siles-Lucas S, Gottstein B. Review: molecular tools for the diagnosis of cystic and alveolar echinococcosis. Trop Med Int Health 2001; 6:463-475.
41. Liance M, Janin V, Bresson-Hadni S, Vuitton DA, Houin R, Piarroux R. Immunodiagnosis of Echinococcus infections: confirmatory testing and species differentiation by a new commercial WesternBlot. J Clin Microbiol 2000; 38:3718-3721.
42. Poretti D, Felleisen E, Grimm F, et al. Differential immunodiagnosis between cystic hydatid disease and other cross-reactive pathologies. Am J Trop Med Hyg 1999; 60:193-198.
43. Pfister M, Gottstein B, Cerny T, et al. Immunodiagnosis of echinococcosis in cancer patients. Clin Microbiol Infect 1999; 5:693-697.
44. Dar FK, Buhidma MA, Kidwai SA. Hydatid false positive serological test results in malignancy. BMJ 1984; 288:1197.
45. Ben-Ismail R, Rouger P, Carme B, et al. Comparative automated assay of anti-P1 antibodies in acute hepatic distomiasis (fasciolasis) and in hyda-tidosis. Vox Sang 1980; 38:156-168.
46. Pinon JM, Poirriez J, Lepan J, et al. Value of isotypic characterization of antibodies of Echinococcus granulosus by enzyme-linked immuno-filtration assay. Eur J Clin Microbiol 1987; 6:291-295.
47. Wattal C, Mohan C, Agarwal SC. Evaluation of specific immunoglogulin E by enzyme-linked immunosorbent assay in hydatid disease. Int Arch Allergy Appl Immunol 1987; 87:98-100.
48. Rigano R, Profumo E, Ioppolo S, Notargiacomo S, Ortona E, Teggi A, Siracusano A. Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease. Clin Exp Immunol 1995; 102:281-285.
49. Bonifacino R, Carter SD, Craig PS, Almeida I, Da Rosa D. Assessment of the immunological surveillance value of humoral and lymphocyte assays in severe human cystic echinococcosis. Trans R Soc Trop Med Hyg 2000; 94(1):97-102.
50. Ferragut G, Ljungstrom I, Nieto A. Relevance of circulating antigen detection to follow-up experimental and human cystic hydatid infections. Parasite Immunol 1998; 20:541-549.
51. Lightowlers MW, Liu D, Haralambous A, et al. Subunit composition and specificity of the major cyst fluid antigens of Echinococcus granulosus. Mol Biochem Parasitol 1989; 37:171-182.
52. Stefaniak J. Fine needle aspiration biopsy in the differential diagnosis of the liver cystic echinococcosis. Acta Tropica 1997; 67:107-111.
53. MacPherson CNL, Romig T, Zehyle E, et al. Portable ultrasound scanner versus serology in screening for hydatid cysts in a Nomadic population. Lancet 1987; ii:259-261.
54. Shambesh MA, Craig PS, Macpherson CN, et al. An extensive ultrasound and serologic study to investigate the prevalence of human cystic echinococcosis in northern Libya. Am J Trop Med Hyg 1999; 60:462-468.
55. Reuter S, Niissle K, Kolokythas O, et al. Alveolar liver echinococcosis: a comparative study of three imaging techniques. Infection 2001; 29:119-125.
56. Ammann RW, Hoffmann AF, Eckert J. Swiss study of chemotherapy of alveolar echinococcosis—review of a 20-year clinical research project. Schweiz Med Wochenschr 1999; 129:323-332.
57. Kasai Y, Koshino I, Kawanishi N, et al. Alveolar echinococcosis of the liver. Studies on 60 operated cases. Ann Surg 1980; 192:145-152.
58. Diebold-Berger S, Khan H, Gottstein B et al. Cytologic diagnosis of isolated pancreatic alveolar hydatid disease with immunologic and PCR analyses—a case report. Acta Cytolo 1997; 41:1381-1386.
59. Gottstein B, Jacquier P, Bresson-Hadni S, et al. Improved primary immuno-diagnosis of alveolar echinococcosis in humans by an enzyme-linked immunosorbent assay using the Em2plus-antigen. J Clin Microbiol 1993; 31:373-376.
60. Lightowlers M, Gottstein B. Immunodiagnosis of echinococcosis. In: Thompson RCA, Lymbery AJ, eds. Echinococcus and Hydatid Disease. Wallingford: CAB International, 1995.
61. Frosch PM, Frosch M, Pfister T, Schaad V, Bitter-Suermann D. Cloning and characterisation of an immunodominant major surface antigen of Echinococcus multilocularis. Mol Biochem Parasitol 1991; 48:121-130.
62. Xiao N, Mamuti W, Yamasaki H, Sako Y, Nakao M, Nakaya K, Gottstein B, Schantz PM, Lightowlers MW, Craig PS, Ito A. Evaluation of recombinant Em18 and affinity-purified Em18 for serological differentiation alveolar echinococcosis from cystic echinococcosis and other parasitic infections. J Clin Microbiol 2003; 41:3351-3353.
63. Bresson-Hadni S, Laplante J, Lenys D, et al. Seroepidemiologic screening of Echinococcus multilocularis infection in a European area endemic for alveolar echinococcosis. Am J Trop Med Hyg 1994; 51:837-846.
64. Gottstein B, Saucy F, Deplazes P, et al. Is a high prevalence of Echinococcus multilocularis in wild and domestic animals associated with increased disease incidence in humans? Emerg Inf Dis 2001; 7:408-412.
65. Rausch RL, Wilson JF, Schantz PM, et al. Spontaneous death of Echinococcus multilocularis: Cases diagnosed serologically by Em2-ELISA and clinical significance. Am J Trop Med Hyg 1987; 36:576-585.
66. Romig T, Kratzer W, Kimmig P, et al. An epidemiological survey of human alveolar echinococcosis in southwestern Germany. Am J Trop Med Hyg 1999; 6:566-573.
67. Gottstein B, Bettens F, Parkinson AJ, Wilson F. Immunological parameters associated with susceptibility or resistance to alveolar hydatid disease in Yupiks/Inupiats. Arctic Med Res 1996; 55:14-19.
68. Sako Y, Nakao M, Nakaya K, Yamasaki H, Gottstein B, Lightowers MW, Schantz PM, Ito A. Alveolar echinococcosis: characterization of diagnostic antigen Em18 and serological evaluation of recombinant Em18. J Clin Microbiol 2002; 40:2760-2765.
69. Gottstein B, Tschudi K, Eckert J, et al. Em2-ELISA for the follow-up of alveolar echinococcosis after complete surgical resection of liver lesions. Trans R Soc Trop Med Hyg 1989; 83:389-393.
70. Lanier AP, Trujillo DE, Schantz PM, et al. Comparison of serologic tests for the diagnosis and follow-up of alveolar hydatid disease. Am J Trop Med Hyg 1987; 37:609-615.
71. Gottstein B, Mowatt MR. Sequencing and characterization of an Echinococcus multilocularis DNA probe and its use in the polymerase chain reaction. Mol Biochem Parasitol 1991; 44:183-194.
72. Reuter S, Seitz HM, Kern P, et al. Extrahepatic alveolar echinococcosis without liver involvement: a rare manifestation. Infection 2000; 28:187-192.
73. Safioleas M, Misiakos EP, Dosios T, et al. Surgical treatment for lung hydatid disease. World J Surg 1999; 23:1181-1185.
74. Kondov G, Spirovski Z, Joves S, et al. Surgical treatment of hydatid cysts in the pleural space. Int Arch Hydatidosis 2001; 34:186.
75. Altiay G, Tabakoglu E, Kose S, et al. Radiological appearances of our pulmonary hydatid cysts cases. Int Arch Hydatidosis 2001; 34:180.
76. Turna A, Yilmaz MA, Haciibrahimoglu G, Kutlu CA, Bedirhan MA. Surgical treatment of pulmonary hydatid cysts: is capitonnage necessary? Ann Thorac Surg 2002; 74(1):191-195.
77. Mawhorter S, Temeck B, Chang R, et al. Nonsurgical therapy for pulmonary hydatid cyst disease. Chest 1997; 112:1432-1436.
78. Cangiotti L, Giulini S M, Muiesan P, et al. Hydatid disease of the liver: longterm results of surgical treatment. J Chir 1991; 12:501-504.
79. Novick RJ, Tchervenkov CI, Wilson JA, et al. Surgery for thoracic hydatid disease: a North American experience. Ann Thorac Surg 1987; 43:681-686.
80. Keshmiri M, Baharvahdat H, Fattahi SH, et al. A placebo controlled study of albendazole in the treatment of pulmonary echinococcosis. Eur Respir J 1999; 14:503-507.
81. Frider B, Larrieu E, Odriozola M. Long-term outcome of asymptomatic liver hydatidosis. J Hepatol 1999; 30:228-231.
82. Cobo F, Yarnoz C, Sesma B, et al. Albendazole plus praziquantel versus albendazole alone as a pre-operative treatment in intra-abdominal hydatisosis caused by Echinococcus granulosus. Trop Med Int Health 1998; 3:462-566.
83. Messaritakis J, Psychou P, Nicolaidou P, Karpathios T, Syriopoulou B, Fretzayas A. High mebendazole doses in pulmonary and hepatic hydatid disease. Arch Dis Child 1991; 66:532-533.
84. Morris DL. Pre-operative albendazole therapy for hydatid cyst. Br J Surg 1987; 74:805-806.
85. Partensky C, Landraud R, Valette P-J, et al. Radical and nonradical hepatic resection for alveolar echinococcosis: report of 18 cases. World J Surg 1990; 14:654-659.
86. Chinnery JB, Morris DL. Effect of albendazole sulphoxide on viability of hydatid protoscolices in vitro. Trans R Soc Trop Med Hyg 1986; 80: 815-817.
87. Taylor DH, Morris DL. Combination chemotherapy is more effective in postspillage prophylaxis for hydatid disease than either albendazole or praziquantel alone. Br J Surg 1989; 76:954.
88. Braithwaite PA, Roberts MS, Allan RJ, et al. Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease. Eur J Clin Pharmacol 1982; 22:161-169.
89. Marriner SE, Morris DL, Dickson B, et al. Pharmacokinetics of albendazole in man. Eur J Clin Pharmacol 1986; 30:705-708.
90. Luder PJ, Robotti G, Meister FP, et al. High oral doses of mebendazole interfere with growth of larval echinococcus multilocularis lesions. J Hepatol 1985; 1:369-377.
91. Luder PJ, Siffert B, Witassek F, et al. Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions. Eur J Clin Pharmacol 1986; 31:443-448.
92. Horton RJ. Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Trop 1997; 64:79-93.
93. Luchi S, Vincenti A, Messina F, et al. Albendazole treatment of human hydatid tissue. Scand J Infect Dis 1997; 29:165-167.
94. Cotting J, Zeugin T, Steiger U, et al. Albendazole kinetics in patients with echinococcosis: delayed absorption and impaired elimination in cholestasis. Eur J Clin Pharmacol 1990; 38:605-608.
95. Davis A, Dixon H, Pawlowski ZS. Multicentre clinical trials of benzimidazole carbamates in human cystic echinococcosis (phase 2). Bull World Health Organ 1986; 67:503-508.
96. Aktan AO, Yalin R. Preoperative albendazole treatment for liver hydatid disease decreases the viability of the cyst. Eur J Gastroenterol Hepatol 1996; 8:877-879.
97. French CM. Mebendazole and surgery for human hydatid disease in Turkana. East Afr Med J 1984; 61:113-119.
98. Morris DL, Dykes PW, Marriner S, et al. Albendazole: objective evidence of response in human hydatid disease. JAMA 1985; 253:2053-2057.
99. Henriksen TH, Klungsoyr P, Zerihun D. Treatment of disseminated peritoneal hydatid disease with praziquantel. Lancet 1989; 1:272.
100. Piens MA, Persat F, May et al. Praziquantel in human hydatidosis. Evaluation by preoperative treatment. Bull Soc Pathol Exot Filiales 1989; 82:503-512.
101. Taylor DH, Morris DL, Reffin D, et al. Comparison of albendazole, mebendazole and praziquantel chemotherapy of Echinococcus multilocularis in a ger-bil model. Gut 1989; 30:1401-1405.
102. Wang X, Liu Y, Yu D. Continuous therapy with albendazole for hepatic alveolar echinococcosis associated with obstructive jaundice. Chung Hua Nei Ko Tsa Chih 1996; 35:261-264.
103. Luder PJ, Witassek F, Weigand K, et al. Treatment of cystic echinococcosis (Echinococcus granulosus) with mebendazole: assessment of bound and free drug levels in cyst fluid and of parasite vitality in operative specimens. Eur J Clin Pharmacol 1985; 28:279-285.
104. Ammann R, Tschudi K, von Ziegler M, et al. Langzeitverlauf bei 60 Patien-ten mit alveolaerer Echinokokkose unter Dauertherapie mit Mebendazol (1976-1985). Klin Wochenschr 1988; 66:1060-1073.